Financials

  • Market Capitalization 764.96 M
  • Employee 618
  • Founded 1997
  • CEO N/A
  • Website www.gyretx.com
  • Headquarter Delaware, United States
  • FIGI BBG000F88SY8
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-38.76
Relación precio/flujo de caja
5.5

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2630
NGNE
Neurogene Inc. - Common Stock
38.60 USD+2.63%+8.64%+7.19%+31.20%772.44 M USD
2634
PHAT
Phathom Pharmaceuticals, Inc. - Common Stock
9.50 USD+4.97%+3.60%+13.37%-22.70%768.56 M USD
2665
ASMB
Assembly Biosciences, Inc. - Common Stock
36.60 USD+1.30%+8.28%+36.67%+24.38%745.20 M USD
2667
VSTM
Verastem, Inc. - Common Stock
8.20 USD+2.76%+15.49%+38.75%-22.93%742.62 M USD